MedTrace Logo

Hypothermia and Hemostasis After Cardiac Arrest

NCT02258360 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2016-03-29

No results posted yet for this study

Summary

This is a sub-study to the Time-differentiated Therapeutic Hypothermia (TTH48, ClinicalTrials.gov Identifier: NCT01689077). TTH48 compares 24 with 48 hours of therapeutic hypothermia at a target temperature of 32-34°C in survivors of out-of-hospital cardiac arrest.

The overall aim of this sub-study is to examine the hemostasis in patients resuscitated after cardiac arrest and treated with 24 and 48 hours of therapeutic hypothermia

Our specific aims are:

* To investigate the whole blood coagulation using the rotational thromboelastometry.
* To investigate the function of platelets

Conditions

  • Hypothermia
  • Heart Arrest
  • Hemostasis
  • Coagulants

Interventions

OTHER

Therapeutic hypothermia

Therapeutic hypothermia with a target temperature between 32-34°C.

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Anni Norgaard Jeppesen, MD · Research Center of Emergency Medicine and Department of Anesthesiology and Intensive Care Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-06-30
Completion
2017-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02258360 on ClinicalTrials.gov